Ignite Creation Date:
2024-05-19 @ 5:34 PM
Last Modification Date:
2024-10-26 @ 3:29 PM
Study NCT ID:
NCT06412120
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-05-16
First Post:
2024-05-08
Brief Title:
Study Evaluating Safety Tolerability and Metabolism of Niraparib
Sponsor:
University of Miami
Organization:
University of Miami
Study Overview
Official Title:
Single-Arm Prospective Multicenter Study Evaluating Safety Tolerability and Metabolism of Niraparib as Maintenance Following Front-Line Treatment for Ovarian Cancer in Women of African Ancestry
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to identify the genetic characteristics specifically degree of African ancestry and environmental characteristics that appear to be related to the effects both good and bad that the maintenance treatment has women with ovarian cancer In this study an investigational medication called niraparib is being tested for the treatment of ovarian cancer Niraparib works by blocking the ability of cancer cells to fix their genes Cancer cells with damaged genes have a harder time growing and spreading in the body and can even die
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None